expanded access program Archives

PubMed is a free, comprehensive database of scientific and medical literature, primarily focusing on biomedical and life sciences research. It is maintained by the National Library of Medicine (NLM) at the National Institutes of Health (NIH). PubMed is one of the most widely used resources for healthcare professionals, researchers, and students to access peer-reviewed articles, clinical studies, and other scientific publications.

Canna~Fangled Abstracts

Pharmacogenetic predictors of cannabidiol (CBD) response and tolerability in treatment-resistant epilepsy

Clin Pharmacol Ther. 2021 Aug 31. doi: 10.1002/cpt.2408. Online ahead of print. Brittney H Davis 1, T…

Freedom WaresAugust 31, 2021

Canna~Fangled Abstracts

Results From an Italian Expanded Access Program on Cannabidiol Treatment in Highly Refractory Dravet Syndrome and Lennox-Gastaut Syndrome

Front Neurol. 2021 May 20;12:673135. doi: 10.3389/fneur.2021.673135. eCollection 2021. Luigi Francesco Iannone 1, Gabriele Arena 1, Domenica Battaglia 2, Francesca Bisulli 3 4, Paolo Bonanni 5, Antonella…

Freedom WaresMay 20, 2021

Canna~Fangled Abstracts

Long-term safety and efficacy of cannabidiol in children and adults with treatmentresistant Lennox-Gastaut syndrome or Dravet syndrome: Expanded access program results.

Epilepsy Res. 2019 Mar 25;154:13-20. doi: 10.1016/j.eplepsyres.2019.03.015. Laux LC1, Bebin EM2, Checketts D3, Chez M4,…

Freedom WaresMarch 25, 2019

Canna~Fangled Abstracts

Long-term safety and treatment effects of cannabidiol in children and adults with treatment-resistant epilepsies: Expanded access program results.

Epilepsia. 2018 Jul 12. doi: 10.1111/epi.14477. Szaflarski JP1, Bebin EM1, Comi AM2, Patel AD3, Joshi…

Freedom WaresJuly 12, 2018

expanded access program

Pharmacogenetic predictors of cannabidiol (CBD) response and tolerability in treatment-resistant epilepsy

Results From an Italian Expanded Access Program on Cannabidiol Treatment in Highly Refractory Dravet Syndrome and Lennox-Gastaut Syndrome

Long-term safety and efficacy of cannabidiol in children and adults with treatmentresistant Lennox-Gastaut syndrome or Dravet syndrome: Expanded access program results.

Long-term safety and treatment effects of cannabidiol in children and adults with treatment-resistant epilepsies: Expanded access program results.

Recent Posts

Archives

Categories